Prakt. lékáren. 2012; 8(2): 80-84

Extemporaneously prepared pediatric dosage forms, part II - oral liquids and suspensions

Sylva Klovrzová1, Zdeňka Šklubalová2
1 Nemocniční lékárna FN v Motole, Praha
2 UK v Praze, Farmaceutická fakulta, Katedra farmaceutické technologie, Hradec Králové

The extemporaneously prepared pediatric oral liquid dosage forms particularly include aqueous solutions and suspensions. A guarrantee

of their stability, the precise dosing, and the appropriate taste are the basic requirements. The choice of pharmaceutical excipients is

limited due to their safety for pediatric patients. This review summarizes the excipients suitable in a formulation of the extemporaneously

prepared pediatric oral liquids.

Keywords: extemporaneous preparation, pediatric dosage forms, oral liquids, excipients, stability

Published: April 23, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Klovrzová S, Šklubalová Z. Extemporaneously prepared pediatric dosage forms, part II - oral liquids and suspensions. Praktické lékárenství. 2012;8(2):80-84.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Klovrzová S. Pediatrické lékové formy v magistraliter přípravě - I. část, Prakt lékáren 2011; 7(6): 276-278.
    2. Český lékopis 2009, doplněk 2010, Grada Publishing, a.s., Praha 2010: 5357.
    3. http://www.nemlek.cz/index.php/pripravky-pro-pediatrii, k 23.10.2011.
    4. A Guideline on SmPC z 9/2009, The Rules Governing Medicinal Products in the EU, Vol. 2C Notice to Applicants, k 15.1.2012. http://ec.europa.eu/health/files/eudralex/vol2/c/smpc_guideline_rev2_en.pdf.
    5. Woods D. Extemporaneus Formulations of Oral Liquids, k 23.10.2011. http://www.pharminfotech.co.nz/manual/Formulation/extemprep.pdf.
    6. Komárek P, Rabišková M. Technologie léků, 3. vydání, Galén, 2006: 399.
    7. Hurtado J, Moffett BS. Pediatric oral formulations: a continual challenge. Int J Pharm Compound 2007; 11(1): 17-19.
    8. Katdare A, Chaubal MV, et al. Excipient Development for Pharmaceutical, Biotechnology und Drug Systems, Informa Healthcare USA, Inc, New York, 2006: 388. Go to original source...
    9. Thompson JE. A Practical Guide to Contemporary Pharmacy Practice, 3th Ed., Lippincott Williams & Wilkins, Baltimore, 2009: 738.
    10. EMEA/CHMP/PEG/194810/2005: Reflection Paper: Formulations of choise for the pediatric population, k 23.10.2011. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/200 9/0 9/WC500003782.pdf.
    11. UNITED STATES PHARMACOPEIAL CONVENTION: United States Pharmacopoeia - national formulary 27, 32th Ed., Rockville, 2008: 3901.
    12. PADDOCK LABORATORIES: Products, Educations - Secundum Artem. 23.10.2011. www.paddocklabs.com.
    13. Embrechts R, Ariën A. Antimicrobial preservation of oral liquid formulations for children. Poster presentation. 3rd PharmSciFair: Pharmaceutical Sciences for the future of medicine, Praha 13.-17. 6. 2011.
    14. WHO 2000: Benzoic Acid and Sodium Benzoate. k 28.6.2011. http://www.who.int/ipcs/publications/cicad/en/cicad26.pdf.
    15. Rowe RC, Sheskey PJ, Owen SC. Handbook of Pharmaceutical excipients, 5th Ed., 2006, Pharmaceutical Press and American Pharmacist Association, London, 918.
    16. DEUTSCHER ARZNEIMITTEL-CODEX (DAC)/NEUES REZEPTUR-FORMULARIUM (NRF) 2009, Govi-Verlag Eschborn, Deutscher Apotheker-Verlag Stuttgart 2009.
    17. Trissel LA. Stability of compounded formulations. 4th Ed., 2009, American Pharmacists Association, Washington, D. C., 654.
    18. Johnson CE, Cober MP, Ludwig JL. Stability of doses of omeprazole-sodium bicarbonate oral suspension. Ann Pharmacoter 2007; 41(12): 1954-1961. Go to original source... Go to PubMed...
    19. Berger-Gryllaki M, Podilsky G. The development of a stable oral solution of captopril for paediatric patients, EJHP Science 2007; 3: 67-72.
    20. Denyer SP, Baird RM, et al. Guide to microbiological control in pharmaceuticals. Ellis Horwood, Bodmin, 1990: 389.

    Return to the content


    Pharmacy for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.